Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 3
Author(s): Patrick L. Sheets
Affiliation:
Export Options
About this article
Cite this article as:
Sheets L. Patrick, Meet Our Editorial Board Member, Current Drug Targets 2016; 17 (3) . https://dx.doi.org/10.2174/138945011703160125123056
DOI https://dx.doi.org/10.2174/138945011703160125123056 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Current Molecular Medicine The Family B1 GPCR: Structural Aspects and Interaction with Accessory Proteins
Current Drug Targets Comparison of the Ability of Pyridinium Aldoximes to Reactivate Human RBC Cholinesterases Inhibited by Ethyl- and Methyl-Paraoxon
Current Organic Chemistry Computer-Aided Drug Design of Bioactive Natural Products
Current Topics in Medicinal Chemistry Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Thin, Stubby or Mushroom: Spine Pathology in Alzheimers Disease
Current Alzheimer Research Long Term Caregiving: Helping Families of Persons with Mild Cognitive Impairment Cope
Current Alzheimer Research Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness
Current Pharmaceutical Design Statin-Like Drugs for the Treatment of Brain Cholesterol Loss in Alzheimers Disease
Current Drug Safety Sustained Release In Situ Implant of Arteether Based on Transition of Smedds into Lyotropic Liquid Crystalline Phases
Current Nanomedicine Editorial [Hot Topic: New Prospects for Treatment of Autoimmune Diseases (Executive Guest Editor: Alessandra Fierabracci)]
Current Pharmaceutical Design Does Pharmacological Therapy Still Play a Role in Preventing Sudden Death in Surgically Treated Tetralogy of Fallot?
Mini-Reviews in Medicinal Chemistry Buprenorphine and Buprenorphine/Naloxone Intoxication in Children – How Strong is the Risk?
Current Drug Abuse Reviews Recent Advances in the Synthesis of Naratriptan: An Anti-Migraine Drug
Mini-Reviews in Organic Chemistry Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Current Molecular Pharmacology Sphingolipid Modulation: A Strategy for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update
Current Drug Metabolism Speed Matching Interaction between Visual and Tactile Motion
Neuroscience and Biomedical Engineering (Discontinued) 2, 7-Diarylidene-cycloheptanone, Hydrazonoyl Chlorides and Heterocyclic Amines as Precursors for Synthesis of Bioactive new Fused Cycloheptapyrimidine Derivatives
Current Organic Synthesis